Related Experiment Videos

Statin in combination with β-blocker therapy reduces postoperative stroke after coronary artery bypass graft surgery

Denis Bouchard1, Michel Carrier, Philippe Demers

  • 1Department of Cardiac Surgery, Montreal Heart Institute, Université de Montréal, Montreal, Quebec, Canada. denis.bouchard@icm-mhi.org

The Annals of Thoracic Surgery
|March 1, 2011
PubMed

Insights

Preoperative statin and beta-blocker combination therapy significantly reduces stroke risk after coronary artery bypass grafting (CABG). This combination offers a protective effect against postoperative neurological complications in cardiac surgery patients.

Area of Science:

  • Cardiovascular Surgery
  • Neurology
  • Pharmacology

Background:

  • Statin therapy is known to prevent perioperative events and reduce stroke risk in non-cardiac surgery contexts.
  • Limited research exists on statin therapy's preventive effect on neurological outcomes specifically after coronary artery bypass grafting (CABG).

Purpose of the Study:

  • To investigate the impact of preoperative medication, including statins, on neurologic outcomes following CABG.
  • To identify specific drug combinations that may reduce the risk of postoperative stroke in patients undergoing CABG.

Main Methods:

  • Analysis of 6,813 patients undergoing CABG between 1995-2005 with complete medication histories.
  • Utilized multiple logistic regression to assess risk factors for postoperative stroke, focusing on preoperative statin, aspirin, beta-blocker, and ACE inhibitor use.

Main Results:

  • The overall incidence of stroke within 30 days post-CABG was 1.4% (94 patients).
  • Hypertension, carotid disease, diabetes, and age were identified as significant risk factors for stroke.
  • No single medication demonstrated a protective effect alone; however, the combination of statins and beta-blockers showed a strong protective effect (OR 0.377).

Conclusions:

  • Combined preoperative use of beta-blockers and statins confers a significant protective effect against stroke after CABG.
  • This drug combination may be a key strategy for improving neurological outcomes in cardiac surgery patients.
Abstract

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
Heart Failure Drugs: β-Blockers01:22

Heart Failure Drugs: β-Blockers

β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation, vasodilation, and...